Pharmacological purging of bone marrow with reference to autografting

Clin Haematol. 1986 Feb;15(1):67-83. doi: 10.1016/s0308-2261(86)80006-6.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Bleomycin / therapeutic use
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Bone Marrow Transplantation*
  • Cell Separation
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / analogs & derivatives
  • Cyclophosphamide / therapeutic use
  • Drug Evaluation
  • Etoposide / therapeutic use
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / pathology
  • Leukemia / therapy
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Lymphoid / therapy
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Lymphoma / therapy
  • Lysophosphatidylcholines / therapeutic use
  • Methylprednisolone / therapeutic use
  • Neoplasms, Experimental / drug therapy
  • Phospholipid Ethers*
  • Pyrimidinones / therapeutic use
  • Transplantation, Autologous
  • Transplantation, Isogeneic

Substances

  • Lysophosphatidylcholines
  • Phospholipid Ethers
  • Pyrimidinones
  • Bleomycin
  • edelfosine
  • merocyanine dye
  • Etoposide
  • Asta Z 7557
  • Cyclophosphamide
  • perfosfamide
  • Methylprednisolone